Search

Search Constraints

Start Over Filtering by: Keyword immune checkpoint inhibitors Remove constraint Keyword: immune checkpoint inhibitors

Search Results

  • Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck
  • Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma
  • Eganelisib, a First-in-Class PI3K-𝛾 Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial
  • Global circumferential and radial strain among patients with immune checkpoint inhibitor myocarditis
  • Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research
  • Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer
  • Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer
  • Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States
  • Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience
  • Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access